Finally, analyzing patient-derived breast cancer tissue confirmed that TRPV4 is primarily localized to the plasma membrane in high-grade DCIS, but not in lower-grade DCIS or less aggressive cases. The gene discussed is TRPV4; the disease is ductal breast carcinoma in situ.